NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/20/2025
Back to search
Official data from USPTO
BOBCAT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
05/20/2025
Trademark type
Word
Nice classes
5
Filing date
10/03/2023
Registration date
05/20/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/20/2025
Last transaction
05/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/06/2024
First use in commerce
11/06/2024
Drawing code
4
Owner type
03
Owner location
Baltimore, MD, US
Examiner
MCCARTHY, BRIDGET ANN
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Elixirgen Therapeutics, Inc.
Representatives
Leonard D. Bowersox KILYK & BOWERSOX, P.L.L.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsRNA dosage medium preparations carrying genes encoding proteins for treating or preventing genetic diseases; pharmaceutical preparationsRNA dosage medium preparations carrying genes encoding proteins for treating or preventing infectious diseases; pharmaceutical preparationsRNA dosage medium preparations carrying genes encoding proteins for treating or preventing cancers; pharmaceutical preparationsRNA dosage medium preparations carrying genes encoding proteins for treating or preventing age-related diseases; pharmaceutical preparationsRNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for gene editing being for the treatment of genetic disorders; pharmaceutical preparationsRNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for treating genetic disorders in the nature of telomere shortening; pharmaceutical preparationsRNA dosage medium preparations carrying genes encoding proteins for regenerative medicine in the nature of cell rejuvenation
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/20/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/28/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/28/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/28/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/28/2025
ALIE
ASSIGNED TO LIE
04/28/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/10/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/02/2025
GNRT
NON-FINAL ACTION E-MAILED
04/02/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
04/02/2025
DOCK
ASSIGNED TO EXAMINER
03/24/2025
EEXT
SOU TEAS EXTENSION RECEIVED
03/21/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/11/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/10/2025
IUAF
USE AMENDMENT FILED
11/27/2024
EISU
TEAS STATEMENT OF USE RECEIVED
11/27/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/24/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/30/2024
PUBO
PUBLISHED FOR OPPOSITION
07/30/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/10/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/21/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/20/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/20/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/29/2024
GNRT
NON-FINAL ACTION E-MAILED
05/29/2024
CNRT
NON-FINAL ACTION WRITTEN
05/29/2024
DOCK
ASSIGNED TO EXAMINER
05/23/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/12/2023
NWAP
NEW APPLICATION ENTERED
10/06/2023
Continuous trademark protection
Get notified about every new filing that threatens BOBCAT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.